Active Ingredient: MONTELUKAST SODIUM
Proprietary Name: MONTELUKAST SODIUM
Dosage Form; Route of Administration: TABLET, CHEWABLE; ORAL
Strength: EQ 4MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A205107
Product Number: 001
Approval Date: Sep 4, 2020
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS OF NEW YORK LLC
Marketing Status:
Prescription
Patent and Exclusivity Information